Moreover, even in the absence of this deletion, a synergistic in vitro activity of the combination of an ALK inhibitor with a CDK inhibitor in neuroblastoma was reported in the literature (Wood et al. 2017). This evidence concerns the gene ALK and neuroblastoma.